Eichenfield Lawrence Insider Trades

Insider Trading History

Track insider trading activity for Eichenfield Lawrence. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Verrica Pharmaceuticals
Verrica Pharmaceuticals VRCA
Director
Holding Value $117k 20,000 shares
Last Trade
Jun 05, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$11.6k 20,000 shares
$0.58
$5.87
Forte Biosciences
Forte Biosciences FBRX
Director
Holding Value $850k 50,000 shares
Last Trade
Aug 20, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$413k 50,000 shares
$8.25
$17.00
Verrica Pharmaceuticals
Verrica Pharmaceuticals VRCA
Director
Holding Value $117k 20,000 shares
Last Trade
Jun 06, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$176k 20,000 shares
$8.78
$5.87
Forte Biosciences
Forte Biosciences FBRX
Director
Holding Value $425k 25,000 shares
Last Trade
Sep 19, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$500k 25,000 shares
$20.00
$17.00
Verrica Pharmaceuticals
Verrica Pharmaceuticals VRCA
Director
Holding Value $61k 10,384 shares
Last Trade
Jun 08, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$59.2k 10,384 shares
$5.70
$5.87
Verrica Pharmaceuticals
Verrica Pharmaceuticals VRCA
Director
Holding Value $61k 10,384 shares
Last Trade
Jun 09, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$22.3k 10,384 shares
$2.15
$5.87
Forte Biosciences
Forte Biosciences FBRX
Director
Holding Value $425k 25,000 shares
Last Trade
Jun 01, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$794k 25,000 shares
$31.75
$17.00
Forte Biosciences
Forte Biosciences FBRX
Director
Holding Value $425k 25,000 shares
Last Trade
Feb 23, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$794k 25,000 shares
$31.75
$17.00
Verrica Pharmaceuticals
Verrica Pharmaceuticals VRCA
Director
Holding Value $47.6k 8,109 shares
Last Trade
Jun 10, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$85.6k 8,109 shares
$10.56
$5.87
Verrica Pharmaceuticals
Verrica Pharmaceuticals VRCA
Director
Holding Value $34.2k 5,834 shares
Last Trade
Jun 10, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$61.6k 5,834 shares
$10.56
$5.87
Forte Biosciences
Forte Biosciences FBRX
Director
Holding Value $340k 20,000 shares
Last Trade
May 28, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$17.8M 20,000 shares
$888.50
$17.00
Verrica Pharmaceuticals
Verrica Pharmaceuticals VRCA
Director
Holding Value $0 0 shares
Last Trade
Aug 01, 2020 Sale
$13.1k 2,000 shares
$6.56
$5.87
Verrica Pharmaceuticals
Verrica Pharmaceuticals VRCA
Director
Holding Value $103k 17,502 shares
Last Trade
Aug 01, 2020 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$115k 17,502 shares
$6.56
$5.87
Forte Biosciences
Forte Biosciences FBRX
Director
Holding Value $510k 30,000 shares
Last Trade
Jun 15, 2020 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$14.2M 30,000 shares
$472.50
$17.00
Forte Biosciences
Forte Biosciences FBRX
Director
Holding Value $0 0 shares
Last Trade
Jun 15, 2020 Sale
$2.49M 5,270 shares
$472.50
$17.00

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up